BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12208754)

  • 1. Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase II-directed drugs.
    Ogiso Y; Tomida A; Tsuruo T
    Cancer Res; 2002 Sep; 62(17):5008-12. PubMed ID: 12208754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
    Ogiso Y; Tomida A; Lei S; Omura S; Tsuruo T
    Cancer Res; 2000 May; 60(9):2429-34. PubMed ID: 10811120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose starvation and hypoxia induce nuclear accumulation of proteasome in cancer cells.
    Ogiso Y; Tomida A; Kim HD; Tsuruo T
    Biochem Biophys Res Commun; 1999 May; 258(2):448-52. PubMed ID: 10329407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
    Kim HD; Tomida A; Ogiso Y; Tsuruo T
    J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Import of human and Thermoplasma 20S proteasomes into nuclei of HeLa cells requires functional NLS sequences.
    Wang HR; Kania M; Baumeister W; Nederlof PM
    Eur J Cell Biol; 1997 Jun; 73(2):105-13. PubMed ID: 9208223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear multicatalytic proteinase subunit RRC3 is important for growth regulation in hepatocytes.
    Benedict CM; Clawson GA
    Biochemistry; 1996 Sep; 35(36):11612-21. PubMed ID: 8794741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of eukaryotic 20S proteasome nuclear localization signal.
    Knuehl C; Seelig A; Brecht B; Henklein P; Kloetzel PM
    Exp Cell Res; 1996 May; 225(1):67-74. PubMed ID: 8635518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mithramycin inhibits etoposide resistance in glucose-deprived HT-29 human colon carcinoma cells.
    Lee EM; Park HR; Hwang JH; Park DJ; Chang KS; Kim CJ
    J Microbiol Biotechnol; 2007 Nov; 17(11):1856-61. PubMed ID: 18092471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II.
    Yun J; Tomida A; Nagata K; Tsuruo T
    Oncol Res; 1995; 7(12):583-90. PubMed ID: 8704275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance due to impaired DNA cleavage in a VP-16-resistant human leukemia cell line.
    Fukushima T; Takemura H; Yamashita T; Ishisaka T; Inai K; Imamura S; Urasaki Y; Ueda T
    Anticancer Res; 1999; 19(6B):5111-5. PubMed ID: 10697518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.
    Tomida A; Tsuruo T
    Anticancer Drug Des; 1999 Apr; 14(2):169-77. PubMed ID: 10405643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteasome.
    Kiyomiya K; Satoh J; Horie H; Kurebe M; Nakagawa H; Matsuo S
    Int J Oncol; 2002 Nov; 21(5):1081-5. PubMed ID: 12370758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex.
    Kiyomiya K; Matsuo S; Kurebe M
    Cancer Res; 2001 Mar; 61(6):2467-71. PubMed ID: 11289116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasomes: destruction as a programme.
    Hilt W; Wolf DH
    Trends Biochem Sci; 1996 Mar; 21(3):96-102. PubMed ID: 8882582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the unfolded protein response is necessary and sufficient for reducing topoisomerase IIalpha protein levels and decreasing sensitivity to topoisomerase-targeted drugs.
    Gray MD; Mann M; Nitiss JL; Hendershot LM
    Mol Pharmacol; 2005 Dec; 68(6):1699-707. PubMed ID: 16141312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human topoisomerase IIalpha nuclear export is mediated by two CRM-1-dependent nuclear export signals.
    Turner JG; Engel R; Derderian JA; Jove R; Sullivan DM
    J Cell Sci; 2004 Jun; 117(Pt 14):3061-71. PubMed ID: 15173319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma.
    von Metzler I; Heider U; Mieth M; Lamottke B; Kaiser M; Jakob C; Sezer O
    Exp Cell Res; 2009 Aug; 315(14):2471-8. PubMed ID: 19410573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The import pathway of human and Thermoplasma 20S proteasomes into HeLa cell nuclei is different from that of classical NLS-bearing proteins.
    Mayr J; Wang HR; Nederlof P; Baumeister W
    Biol Chem; 1999 Oct; 380(10):1183-92. PubMed ID: 10595581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of proteasome distribution in living cells.
    Reits EA; Benham AM; Plougastel B; Neefjes J; Trowsdale J
    EMBO J; 1997 Oct; 16(20):6087-94. PubMed ID: 9321388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.